CRISPR Therapeutics AG (CRSP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 4.72B |
| Enterprise Value | 4.76B |
| P/E Ratio | -9.65 |
| PEG Ratio | -1.19 |
| Price/Sales Ratio | 176.3 |
| Price/Book Ratio | 2.69 |
| Enterprise/Revenue | 199.65 |
| Enterprise/EBITDA | -10.93 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -18.12 |
| Operating Margin | -21.05 |
| Return On Assets | -0.18 |
| Return On Equity | -0.26 |
| Revenue | 3.51M |
| Revenue/Share | 0.26 |
| Gross Profit | -229.45M |
| EBITDA | -558.49M |
| Net Income | -581.6M |
| Diluted EPS | -6.47 |
| Total Cash | 2.27B |
| Total Cash/Share | 23.49 |
| Total Debt | 779.83M |
| Total Debt/Equity | 0.47 |
| Current Ratio | 16.21 |
| Book Value Per Share | 17.04 |
| 52-Week Change | -17.13 |
| 52-Week High | 63.45 |
| 52-Week Low | 44.12 |
| Moving Average 50 Days | 52.89 |
| Moving Average 200 Days | 52.68 |
| Average Volume | 1.57M |
| Shares Outstanding | 97M |
| % Held by Institutions | 80.2 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |